191868-23-2

Usage

Uses

Used in Pharmaceutical Industry:
1-(4-Cyanophenyl)-N-methylmethanesulfonamide is used as a research compound for its potential role in cancer treatment. It targets the mTOR pathway, which is often dysregulated in various cancers, making it a promising candidate for developing targeted therapies.
Used in Immunosuppressive Applications:
In the field of immunosuppression, 1-(4-Cyanophenyl)-N-methylmethanesulfonamide is used as an inhibitor of the mTOR kinase, which plays a significant role in the immune response. By inhibiting this pathway, it may help in managing autoimmune diseases and transplant rejection.
Used in Drug Development:
1-(4-Cyanophenyl)-N-methylmethanesulfonamide is utilized in drug development for its potential to treat conditions associated with dysregulated mTOR activity. Its selective inhibition of mTOR kinase makes it a valuable tool in the development of new therapeutic strategies for various diseases, including cancer and immune disorders.

Upstream product

• 56105-99-8 (4-cyano-phenyl)-methanesulfonyl chloride 
• 56105-98-7 sodium (4-cyanophenyl)methanesulfonate 

Downstream Products

• 191868-25-4 (R)-N₅-[Amino(nitroimino)methyl]-N₂-(diphenylacetyl)-N-[[4-(methylaminosulphonylmethyl)phenyl]methyl]-ornithinamide 
• 191868-24-3 4-(Methylaminosulphonylmethyl)benzenemethanamine 

Relevant academic research and scientific papers

OXADIAZOLE COMPOUND AND USE AS PESTICIDE

The present invention provides a compound having excellent control efficacies against pests. Specifically, the present invention provides a compound represented by formula (I): (wherein: A is a single bond, etc.; m is any one integer of 0 to 3; X is a sin

Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them

NPY-antagonistic compounds of the formula STR1 Exemplary are: (A) (R)-N-[[4-(Aminocarbonylaminomethyl)phenyl]methyl]-N 2-bis(4-hydroxyphenyl)acetyl]-argininamide-trifluoracetate;(B) (R)-N-[[4-(Aminocarbonylaminomethyl)phenyl]methyl]-N 2-[bis(4-chlorphenyl)acetyl]-argininamide-trifluoracetate;(C) (R)-N-[[4-Aminocarbonylaminomethyl)phenyl]methyl]-N 2-(diphenylacetyl)-argininamide-trifluoracetate;(D) (R)-N 2-(Diphenylacetyl)-N-[[4-(ethoxycarbonylmethylamino-carbonylaminomethyl) phenyl]methyl]-argininamide-trifluoroacetate;(E) (R,S)-N 5-(Aminoiminomethyl)-N 2-(diphenylacetyl)-N-[(4-hy-droxyphenyl)methyl]-N 5-methyl-ornithinamide-hydrochloride; (F) (R)-N-[[4-(Aminocarbonylmethyl)phenyl]methyl]-N 2-(diphenyl-acetyl)-argininamide-diacetate;(G) (R)-N. sup. 2-(Diphenylacetyl)-N-[[4-(ethylaminocarbonylamino-methyl)-phenyl]methyl]-argininamide-bis-(trifluoroacetate); and,(H) (R)-N. sup.2-(Diphenylacetyl)-N-[[4-(ethoxycarbonylamino-carbonylaminomethyl) phenyl]methyl]-argininamide-trifluoroacetate.